Aduro Biotech Highlights Preclinical Data for Three Programs Reported at the American Association for Cancer Research Annual Meeting

    NEXT STORY
    Novartis presents first-of-its-kind evidence at AAN reinforcing robust and consistent efficacy of AimovigTM* (erenumab) for migraine patients with multiple treatment failures
    PREV STORY
    INNATE PHARMA : Promising anti-tumor activity of monalizumab with cetuximab in SCCHN
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    FIT Biotech Oy: FIT BIOTECH PROMOTES LIISA LAITINEN TO SENIOR VICE PRESIDENT AND CHIEF FINANCIAL OFFICER

    FIT BIOTECH OYCOMPANY RELEASE 4 July 2016 at 10.00 EETFIT BIOTECH PROMOTES LIISA LAITINEN ...

    author_avatar
    NASDAQ Market News

    Synairgen plc – Interim results for the six months ended 30 June 2020

    author_avatar
    NASDAQ Market News

    Immunovaccine Forms Inaugural Scientific and Clinical Advisory Committee

    HALIFAX, Nova Scotia, June 14, 2017 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a ...

    author_avatar
    NASDAQ Market News